Cargando…
Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
Acute promyelocytic leukemia (APL) is a rare acute leukemia generally considered curable with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). Some patients have co-morbidities that may limit the use of these agents and therefore impact curability. Adverse effects of ATO include life-threa...
Autores principales: | Tinajero, Jose, El-Shami, Khaled, Wu, Xiaojun, Smith, B. Douglas, Newman, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968060/ https://www.ncbi.nlm.nih.gov/pubmed/35371914 http://dx.doi.org/10.1016/j.lrr.2022.100304 |
Ejemplares similares
-
Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
por: Au, Wing-Yan, et al.
Publicado: (2012) -
Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide
por: Hashimoto, Akiko, et al.
Publicado: (2021) -
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
por: Hashimoto, Akiko, et al.
Publicado: (2021) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014) -
On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)